Description
Product details
GLIBEMIDE FORTE Glibenclamide (5mg), Metformin HCI (500mg) GLIBEMIDE FORTE is a combination medication containing two active ingredients: Glibenclamide (5mg) and Metformin HCI (500mg). This combination is formulated to offer dual-action glucose-lowering therapy for the management of type 2 diabetes mellitus. Glibenclamide, also known as glyburide, belongs to the sulfonylurea class of medications. It works by stimulating the release of insulin from the pancreatic beta cells, thereby increasing insulin secretion. This helps lower blood glucose levels by promoting the uptake of glucose into cells and reducing hepatic glucose production. Metformin HCI is a biguanide medication that primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, such as muscle and fat. It also reduces intestinal absorption of glucose, leading to lower postprandial glucose levels. By combining Glibenclamide and Metformin HCI, GLIBEMIDE FORTE addresses multiple pathophysiological defects underlying type 2 diabetes. Glibenclamide stimulates insulin secretion, while Metformin HCI reduces insulin resistance and hepatic glucose output, resulting in improved glycemic control. GLIBEMIDE FORTE is indicated for the treatment of type 2 diabetes mellitus in adults, particularly for patients whose blood sugar levels are not adequately controlled with either Glibenclamide or Metformin HCI alone. This combination medication offers the convenience of fixed-dose therapy, simplifying the treatment regimen for patients with diabetes. As with any medication, GLIBEMIDE FORTE may cause side effects, including hypoglycemia, gastrointestinal disturbances such as nausea, vomiting, or diarrhea, and rarely, allergic reactions. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability. Overall, GLIBEMIDE FORTE provides an effective and convenient option for the management of type 2 diabetes mellitus, offering dual-action glucose-lowering therapy with the combination of Glibenclamide and Metformin HCI. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order Now https://www.sterisonline.com/product/glibemide-forte-133416
